Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of two multimodal analgesic regimens for total knee arthroplasty
ChiCTR2400087851Phase 4Not yet recruiting
- Sponsor
- Xi'an Honghui Hospital
- Start
- Aug 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of celecoxib, oxycodone, tramadol, acetaminophen and fentanyl in knee osteoarthritis (OA) (2 arms), sponsored by Xi'an Honghui Hospital. Primary endpoint: Morphine consumption. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
celecoxiboxycodonetramadolacetaminophenfentanyl
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2400087851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087851.